Prognostic factors to predict the survival in patients with advanced gastric cancer who receive later-line nivolumab monotherapy-The Asahikawa Gastric Cancer Cohort Study (AGCC).

Kazuyuki TanakaHiroki TanabeHiroki SatoChisato IshikawaMitsuru GotoNaoyuki YanagidaHiromitsu AkabaneShiro YokohamaKimiharu HasegawaYohei KitanoYuya SugiyamaKyoko UeharaYu KobayashiYuki MurakamiTakehito KunogiTakahiro SasakiKeitaro TakahashiKatsuyoshi AndoNobuhiro UenoShin KashimaKentaro MoriichiKeisuke SatoSayaka YuzawaMishie TaninoMasaki TaruiishiYasuo SumiYusuke MizukamiMikihiro FujiyaToshikatsu Okumura

Published in: Cancer medicine (2021)

The regional cohort study of nivolumab monotherapy for gastric cancer patients revealed prognostic factors and a nomogram was developed that could predict the probability of survival.

Keyphrases

prognostic factors
combination therapy
open label
free survival
neoadjuvant chemotherapy
radiation therapy